https://www.spandidos-publications.com/10.3892/mmr.2019.10882
Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
through thepi3k aktalantolactonehumanosteosarcoma